These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast]. Korolev VI, Skliar SIu, Ponomarev IN. Vrach Delo; 1988 Jan; (1):59-61. PubMed ID: 3363942 [No Abstract] [Full Text] [Related]
5. [Determination of plasma prolactin in patients with breast dysplasia]. Vázquez Albaladejo C, Ferrer S, Merle S, Sanchis V, Camps Roig J, Giménez Climent J. Rev Esp Oncol; 1983 Jan; 30(3):323-36. PubMed ID: 6571376 [Abstract] [Full Text] [Related]
11. [Carcinoma arising within mammary fibroadenomas. A study of six patients]. Tissier F, De Roquancourt A, Astier B, Espie M, Clot P, Marty M, Janin A. Ann Pathol; 2000 Mar 09; 20(2):110-4. PubMed ID: 10740004 [Abstract] [Full Text] [Related]
12. [Prolactin and human cancer of the breast. I. Levels of correlation]. Cueto Ladrón de Guevara J, Villalba Moreno J, García Puche JL, Pedraza V. Rev Esp Oncol; 1985 Mar 09; 32(3):439-58. PubMed ID: 3870536 [Abstract] [Full Text] [Related]
13. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones. Rose DP, Cohen LA, Berke B, Boyar AP. J Natl Cancer Inst; 1987 Apr 09; 78(4):627-31. PubMed ID: 3470539 [Abstract] [Full Text] [Related]
14. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective. Tarquini B, Benvenuti M, Legnaioli M, Bazzani M, Cagnoni M, Halberg F. Cancer Detect Prev; 1981 Apr 09; 4(1-4):525-34. PubMed ID: 7349819 [Abstract] [Full Text] [Related]
16. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)]. Bischoff J, Rebhan EM, Prestele H, Becker H. Geburtshilfe Frauenheilkd; 1980 Jan 09; 40(1):65-71. PubMed ID: 7353778 [Abstract] [Full Text] [Related]
17. Plasma membrane enzymes in human breast carcinoma: relationship with serum hormones. Ramalingam V, Krishnamoorthy G, Govindarajulu P. Neoplasma; 1993 Jan 09; 40(6):363-7. PubMed ID: 7904728 [Abstract] [Full Text] [Related]
18. [Detection of serum CEA mRNA and CEA proteins in patients with breast cancer and its clinical significance]. Jin T, Chen DF, Gu LH. Zhonghua Zhong Liu Za Zhi; 2007 Mar 09; 29(3):214-5. PubMed ID: 17649640 [No Abstract] [Full Text] [Related]
19. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease. Tarquini A, di Martino L, Malloci A, Kwa HG, van der Gugten AA, Bulbrook RD, Wang DY. Int J Cancer; 1978 Dec 09; 22(6):687-90. PubMed ID: 721323 [Abstract] [Full Text] [Related]
20. Detection of placental protein five (PP5) and pregnancy-specific glycoprotein (SP1) in benign and malignant breast disease. Bremner RD, Nisbet AD, Herriot R, Horne CH, McArdle C, Crawford D, Bohn H. Oncodev Biol Med; 1981 Dec 09; 2(1-2):55-62. PubMed ID: 6975467 [Abstract] [Full Text] [Related] Page: [Next] [New Search]